Cite
HARVARD Citation
Mahil, S. et al. (2022). Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study. Lancet. pp. e42-e52. [Online].